CytoDyn Announces Treatment of the First Patient in its Pivotal Phase 3 COVID-19 Trial in Brazil for Patients with Severe Symptoms

by NASDAQ Market News September 10, 2021

NASDAQ Market News
Click here to email author

Global $49.3 Bn Molecular Diagnostics Market to 2028: Increase in Demand for Point-of-Care Facilities

T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Mu B.1.621 and Iota B.1.526 Variants of the SARS-CoV-2 Virus

Ads